ACPAs are detected in up to 80% of serum from RA individuals and have been reported to be associated with a more severe disease course and disease outcome compared to ACPA-negative RA, and may even precede disease symptoms [9,10,11,12]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.